Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00188318
Status:
COMPLETED
Last Update Posted:
2016-02-09
First Post:
2005-09-09
Brief Title:
Hardwins - Squamous Cell Carcinoma Head Neck SurgeryRT
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Study Overview
Official Title:
A Phase II Study of Hyperfractionated Accelerated Radiotherapy Delivered With Integrated Neck Surgery for Node-positive Cases in Squamous Cell Carcinoma of the Head and Neck
Status:
COMPLETED
Status Verified Date:
2016-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is examining the effects of increasing the dose of radiation given to treat head and neck cancer Radiation doses to the primary cancer are higher than usually given lymph glands of the neck will also be treated at a lower dose Surgery on the lymph glands my be necessary in the future Radiation treatments given in small fractions twice a day allows a higher dose to be delivered than if the treatment was given once a day This study will enroll patients at three sequential increasing dose levels Approximately 40 patients will be enrolled at each dose level
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None